- Home
- NCNA vs NTBL Comparison
NCNA vs NTBL Comparison
Compare NCNA & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- NTBL
- Stock Information
- Founded
- NCNA 1997
- NTBL 2000
- Country
- NCNA United Kingdom
- NTBL United States
- Employees
- NCNA N/A
- NTBL N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- NCNA Health Care
- NTBL Health Care
- Exchange
- NCNA Nasdaq
- NTBL Nasdaq
- Market Cap
- NCNA 6.4M
- NTBL 6.6M
- IPO Year
- NCNA 2017
- NTBL N/A
- Fundamental
- Price
- NCNA $2.83
- NTBL $0.47
- Analyst Decision
- NCNA Buy
- NTBL Strong Buy
- Analyst Count
- NCNA 3
- NTBL 2
- Target Price
- NCNA $87.50
- NTBL $7.00
- AVG Volume (30 Days)
- NCNA 328.2K
- NTBL 51.9K
- Earning Date
- NCNA 08-15-2024
- NTBL 08-14-2024
- Dividend Yield
- NCNA N/A
- NTBL N/A
- EPS Growth
- NCNA N/A
- NTBL N/A
- EPS
- NCNA N/A
- NTBL N/A
- Revenue
- NCNA N/A
- NTBL $313,000.00
- Revenue This Year
- NCNA N/A
- NTBL N/A
- Revenue Next Year
- NCNA N/A
- NTBL N/A
- P/E Ratio
- NCNA N/A
- NTBL N/A
- Revenue Growth
- NCNA N/A
- NTBL 3812.50
- 52 Week Low
- NCNA $2.53
- NTBL $0.45
- 52 Week High
- NCNA $20.25
- NTBL $10.08
- Technical
- Relative Strength Index (RSI)
- NCNA 38.52
- NTBL 35.33
- Support Level
- NCNA $2.64
- NTBL $0.48
- Resistance Level
- NCNA $8.10
- NTBL $0.59
- Average True Range (ATR)
- NCNA 1.42
- NTBL 0.07
- MACD
- NCNA -0.60
- NTBL -0.01
- Stochastic Oscillator
- NCNA 2.33
- NTBL 10.00
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.